購物車
幫助
021-54845833/15800441009
|
Background: |
This gene was identified as a retinoid acid (RA) receptor-responsive gene. It encodes a type 1 membrane protein. The expression of this gene is upregulated by tazarotene as well as by retinoic acid receptors. The expression of this gene is found to be downregulated in prostate cancer, which is caused by the methylation of its promoter and CpG island. Alternatively spliced transcript variant encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]. |
|
Applications: |
WB, IHC, IF |
|
Name of antibody: |
RARRES1 |
|
Immunogen: |
Fusion protein of human RARRES1 |
|
Full name: |
retinoic acid receptor responder (tazarotene induced) 1 (RARRES1), transcript variant 1 |
|
Synonyms: |
LXNL; PERG-1; TIG1 |
|
SwissProt: |
P49788 |
|
IHC positive control: |
human pancreas tissue and carcinoma of human bladder tissue |
|
IHC Recommend dilution: |
30-150 |
|
WB Predicted band size: |
33 kDa |
|
WB Positive control: |
HepG2, Hela, SVT2, A549, COS7, Jurkat, MDCK, MCF-7 cell lysates |
|
WB Recommended dilution: |
500-2000 |
